Importer of Controlled Substances Application: Shertech Laboratories, LLC, 15711 [2021-06031]
Download as PDF
<![CDATA[
15711
Federal Register / Vol. 86, No. 55 / Wednesday, March 24, 2021 / Notices
transition brewing agreement. Between
the two facilities MBC and KBC, we
would have capacity, redundancy and
true economies of scale to execute this
plan completely free from ABI
influence.
I have prepared a spreadsheet with
data from my analysis of the publicly
available information from the new
brewery construction along with
valuation metrics for the company. I can
share this at the appropriate time in our
discussion.
In closing we feel that the divestiture
process was unfairly administered, and
a buyer was selected for their clear ties
to ABI and the desire to maintain
influence. We are still an interested
party and would like the opportunity to
be considered as a buyer for the Kona
Brewing assets within Hawai1i.
Sincerely,
/s/
Garrett W. Marrero
CEO, Founder,
Maui Brewing Co.
[FR Doc. 2021–05988 Filed 3–23–21; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–813]
Importer of Controlled Substances
Application: Shertech Laboratories,
LLC
Drug
code
Controlled substance
I
Cocaine ........................
9041
Schedule
III
The company plans to import
synthetic derivatives of the listed
controlled substance in bulk form to
conduct clinical trials. No other activity
for this drug code is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
[FR Doc. 2021–06031 Filed 3–23–21; 8:45 am]
Shertech Laboratories, LLC
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 23, 2021. Such persons
may also file a written request for a
hearing on the application on or before
April 23, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
DEPARTMENT OF JUSTICE
AGENCY:
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on March 1, 2021,
Shertech Laboratories, LLC, 1185 Woods
Chapel Road, Duncan, South Carolina
29334, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
VerDate Sep<11>2014
16:30 Mar 23, 2021
Jkt 253001
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–812]
Importer of Controlled Substances
Application: Medi-Physics Inc dba GE
Healthcare
hearing on the application on or before
April 23, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on February 26, 2021,
Medi-Physics Inc dba GE Healthcare,
3350 North Ridge Avenue, Arlington
Heights, Illinois 60004–1412, applied to
be registered as an importer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Ecgonine .......................
Drug
code
9180
Schedule
II
The company plans to import
derivatives of the controlled substance
to be used for the manufacture a
diagnostic product and reference
standards. No other activity for this drug
code is authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
[FR Doc. 2021–06030 Filed 3–23–21; 8:45 am]
BILLING CODE 4410–09–P
Medi-Physics Inc dba GE
Healthcare has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 23, 2021. Such persons
may also file a written request for a
SUMMARY:
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–811]
Importer of Controlled Substances
Application: Perkinelmer, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 86, Number 55 (Wednesday, March 24, 2021)]
[Notices]
[Page 15711]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06031]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-813]
Importer of Controlled Substances Application: Shertech
Laboratories, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Shertech Laboratories, LLC has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before April 23, 2021.
Such persons may also file a written request for a hearing on the
application on or before April 23, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 1, 2021, Shertech Laboratories, LLC, 1185 Woods
Chapel Road, Duncan, South Carolina 29334, applied to be registered as
an importer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Cocaine................................ 9041 II
------------------------------------------------------------------------
The company plans to import synthetic derivatives of the listed
controlled substance in bulk form to conduct clinical trials. No other
activity for this drug code is authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-06031 Filed 3-23-21; 8:45 am]
BILLING CODE 4410-09-P
